Tag: Cardioband

ADVERTORIAL: Edwards Cardioband™ Mitral Valve Reconstruction System—Reliably addressing annular dilatation

This content is only for readers outside of the US as it discusses a device that is not FDA approved. In recent years, several transcatheter...

Cardioband becomes first-ever transcatheter tricuspid system to receive the CE mark

Edwards Lifesciences has received the CE mark for the Cardioband tricuspid valve reconstruction system for the treatment of tricuspid regurgitation. The approval means that...

Edwards Lifesciences completes acquisition of Valtech Cardio

Edwards Lifesciences has closed its previously announced acquisition of Valtech Cardio, developer of the Cardioband system for transcatheter repair of the mitral and tricuspid...

Edward Lifesciences to acquire Valtech

Valtech Cardio has agreed to be acquired by Edwards Lifesciences. The acquisition will give Edwards access to Valtech’s Cardioband reconstruction system (Cardioband) for transcatheter...

TCT 2016: Valtech to host symposium about mitral and tricuspid valve...

Valtech Cardio will present a symposium on mitral and tricuspid valve repair at the 2016 Transcatheter Cardiovascular Therapeutics conference (TCT) meeting (29 October–2 November,...

Heart team at Zurich University Hospital use Cardioband for tricuspid repair...

Francesco Maisano (University Hospital Zurich, Zurich, Switzerland) led a team of cardiac surgeons and cardiologists to perform percutaneous direct annuloplasty with the Cardioband system (Valtech)...

PCRLV 2016: MitraClip may be “safe and feasible” for treating tricuspid...

A first-in-man study indicates that percutaneous edge-to-edge repair with Abbott Vascular’s MitraClip system is a safe and feasible treatment for tricuspid regurgitation. According to...